Thursday, April 30, 2026

Samsung’s Onyx Screen Makes Movie Nights Way Brighter—and Sharper

Samsung unveils Onyx, a cinema LED screen with 4K resolution and HDR, enhancing the movie experience at CineEurope 2025.

Michelle Steel Named First Korean-American Nominee for U.S. Ambassador to South Korea—Implications for Bilateral Ties

Trump nominates Michelle Park Steel as the first U.S. ambassador to South Korea, addressing a significant vacancy amid geopolitical challenges.

North Korea, Early Next Year “Kim Jong-un-ism” Strengthening Observation… Labor Party Regulation Modification Attention

North Korea's upcoming 9th Party Congress may formalize Kim Jong Un's people-first ideology and state-first principles in party governance.

Tag: Biotech

Unlocking Global Biotech: CGB-CIC Innovation Center Launching in 2026

CHA Bio Group partners with CIC to create a global bio-ecosystem, enhancing support for biotech firms in cell and gene therapy.

Unlocking Opportunities: Highlights from the 2026 J.P. Morgan Healthcare Conference in San Francisco

The 44th JP Morgan Healthcare Conference in San Francisco drew a large crowd of professionals in formal attire early in the morning.

Samsung Biologics Targets Japan’s $12.3 Billion CDMO Market: What You Need to Know

Samsung Biologics expands in Japan, targeting top pharma firms with new CMO brand 'ExellenS' and enhancing production capabilities.

As Wegovy and Mounjaro Soar, Korean Biotechs Seek a Slice of the Obesity Drug Market

South Korean firms are innovating in the GLP-1 obesity treatment market, developing unique drugs to compete with industry leaders.

No More Lab Rats? FDA Shift Spurs AI Boom in Drug Development

AI is transforming drug discovery in pharma, especially after the FDA's shift away from animal testing, enhancing efficiency.

Europe Moves to Ease Biosimilar Rules, Boosting Asia’s Biopharma Giants

EMA's new guidelines aim to simplify biosimilar development, boosting Samsung Bioepis and Celltrion in Europe's growing market.

Top News

- Our Sponsors Ad -

Follow us